Discovery and validation of the tumor-suppressive function of long noncoding RNA PANDA in human diffuse large B-cell lymphoma through the inactivation of MAPK/ERK signaling pathway-Reference-Cited by-同舟云学术

Discovery and validation of the tumor-suppressive function of long noncoding RNA PANDA in human diffuse large B-cell lymphoma through the inactivation of MAPK/ERK signaling pathway

Published:2017-08-07 Issue:42 Volume:8 Page:72182-72196
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Wang Yingjun¹,Zhang Mingzhi¹,Xu Huanan²,Wang Yifei³,Li Zhaoming¹,Chang Yu¹,Wang Xinhuan¹,Fu Xiaorui¹,Zhou Zhiyuan¹,Yang Siyuan¹,Wang Bei¹,Shang Yufeng¹

Affiliation:

1. Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, Henan, China

2. Department of Anorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China

3. Department of Ultrasonography, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring potential roles of long non-coding RNAs in cancer immunotherapy: a comprehensive review;Frontiers in Immunology;2024-08-27

2. Noncoding RNAs in B cell non-Hodgkins lymphoma;Gene;2024-07

3. Lnc-PTCHD4-AS inhibits gastric cancer through MSH2-MSH6 dimerization and ATM-p53-p21 activation;Aging;2023-11-27

4. Exploring the cell-free total RNA transcriptome in diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma patients as biomarker source in blood plasma liquid biopsies;Frontiers in Oncology;2023-10-25

5. lncRNA MALAT1, MEG3, and PANDAR Levels may be Potential Diagnostic Biomarkers in Multiple Myeloma;Medical Records;2023-09-18